IRadimed Corporation
IRMD
$92.50
$1.291.41%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 11.61% | 19.34% | 16.87% | 13.73% | 10.80% |
| Total Depreciation and Amortization | 105.01% | 81.63% | 42.59% | 18.44% | -3.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 71.96% | 353.78% | 209.91% | 59.03% | 76.22% |
| Change in Net Operating Assets | -197.62% | -133.56% | -215.86% | -108.41% | 151.06% |
| Cash from Operations | -0.01% | 11.19% | -2.64% | 6.21% | 71.49% |
| Capital Expenditure | 84.38% | 60.89% | 3.00% | -78.55% | -476.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 34.71% | 39.05% | 19.20% | -23.93% | -52.27% |
| Cash from Investing | 81.23% | 59.42% | 4.49% | -73.03% | -389.63% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -85.12% | -85.12% |
| Repurchase of Common Stock | -240.99% | -237.14% | -272.26% | -35.72% | -30.60% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -94.84% | -96.29% | -9.96% | 28.78% | 17.73% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -108.13% | -109.10% | -22.77% | 24.93% | 13.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -200.00% | -200.00% | -- | -- |
| Net Change in Cash | 36.39% | 16.11% | -143.48% | -3.43% | 64.47% |